{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:01:45Z","timestamp":1792810905901,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jgo.2023.101502","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T04:45:11Z","timestamp":1681879511000},"page":"101502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Recommendations of the International Society of Geriatric Oncology on skin cancer management in older patients"],"prefix":"10.1016","volume":"14","author":[{"given":"Agata","family":"Rembielak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baran","family":"Akagunduz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Aspeslagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Colloca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falalu","family":"Danwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"del Marmol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuck","family":"O'Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marthe","family":"Verhaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rado","family":"Zic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Livesey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2023.101502_bb0005","series-title":"Non-melanoma Skin Cancer","author":"GLOBOCAN","year":"2020"},{"issue":"11","key":"10.1016\/j.jgo.2023.101502_bb0010","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.clon.2019.08.011","article-title":"Evolving role of systemic therapies in non-melanoma skin cancer","volume":"31","author":"Conforti","year":"2019","journal-title":"Clin. Oncol. (R Coll. Radiol.)"},{"issue":"1","key":"10.1016\/j.jgo.2023.101502_bb0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.prro.2019.10.014","article-title":"Definitive and postoperative radiation therapy for basal and squamous cell cancers of the skin: executive summary of an American Society for Radiation Oncology clinical practice guideline","volume":"10","author":"Likhacheva","year":"2020","journal-title":"Pract. Radiat. Oncol."},{"issue":"9","key":"10.1016\/j.jgo.2023.101502_bb0020","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/bjc.2016.304","article-title":"Cancer incidence and mortality projections in the UK until 2035","volume":"115","author":"Smittenaar","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.jgo.2023.101502_bb0025","first-page":"299","article-title":"Cancer in the oldest old in the United States: Current statistics and projections","volume":"3","author":"Gundrum","year":"2012"},{"issue":"1","key":"10.1016\/j.jgo.2023.101502_bb0030","first-page":"269","article-title":"Skin cancers and their risk factors in older persons: a population-based study","volume":"22","author":"Sinikumpu","year":"2022"},{"issue":"7","key":"10.1016\/j.jgo.2023.101502_bb0035","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/ggi.13118","article-title":"Redefining the elderly as aged 75 years and older: proposal from the joint Committee of Japan Gerontological Society and the Japan geriatrics society","volume":"17","author":"Ouchi","year":"2017","journal-title":"Geriatr Gerontol Int"},{"issue":"5","key":"10.1016\/j.jgo.2023.101502_bb0040","doi-asserted-by":"crossref","first-page":"643","DOI":"10.14336\/AD.2017.0503","article-title":"Skin cancer epidemics in the elderly as an emerging issue in geriatric oncology","volume":"8","author":"Garcovich","year":"2017","journal-title":"Aging Dis."},{"issue":"2","key":"10.1016\/j.jgo.2023.101502_bb0045","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jaad.2019.09.009","article-title":"Nonmelanoma skin cancers are more likely to be untreated in elderly patients","volume":"82","author":"Basu","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"issue":"10","key":"10.1016\/j.jgo.2023.101502_bb0050","first-page":"997","article-title":"Potential overdiagnosis of Basal cell carcinoma in older patients with limited life expectancy","volume":"312","author":"Linos","year":"2014"},{"issue":"6","key":"10.1016\/j.jgo.2023.101502_bb0055","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jaad.2017.12.048","article-title":"Comorbidity scores associated with limited life expectancy in the very elderly with nonmelanoma skin cancer","volume":"78","author":"Rogers","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.jgo.2023.101502_bb0060","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/S2468-2667(19)30019-2","article-title":"Measuring population ageing: an analysis of the global burden of disease study 2017","volume":"4","author":"Chang","year":"2019","journal-title":"Lancet Public Health"},{"issue":"1","key":"10.1016\/j.jgo.2023.101502_bb0065","first-page":"14","article-title":"Reflections on aging research from within the National Institute on Aging","volume":"1","author":"Thuault","year":"2021"},{"issue":"1","key":"10.1016\/j.jgo.2023.101502_bb0070","first-page":"149","article-title":"What is comprehensive geriatric assessment (CGA)? An umbrella review Age and ageing","volume":"47","author":"Parker","year":"2018"},{"issue":"5","key":"10.1016\/j.jgo.2023.101502_bb0075","doi-asserted-by":"crossref","first-page":"718","DOI":"10.7326\/0003-4819-108-5-718","article-title":"New issues in geriatric care","volume":"108","author":"Solomon","year":"1988","journal-title":"Ann. Intern. Med."},{"issue":"24","key":"10.1016\/j.jgo.2023.101502_bb0080","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","article-title":"International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer","volume":"32","author":"Wildiers","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.jgo.2023.101502_bb0085","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/gerona\/63.3.308","article-title":"Second and third generation assessment instruments: the birth of standardization in geriatric care","volume":"63","author":"Bernabei","year":"2008","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"5","key":"10.1016\/j.jgo.2023.101502_bb0090","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1159\/000211949","article-title":"Frailty syndrome: a transitional state in a dynamic process","volume":"55","author":"Lang","year":"2009","journal-title":"Gerontology."},{"issue":"8","key":"10.1016\/j.jgo.2023.101502_bb0095","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/jgs.14202","article-title":"Skin cancer in US elderly adults: does life expectancy play a role in treatment decisions?","volume":"64","author":"Linos","year":"2016","journal-title":"J. Am. Geriatr. Soc."},{"issue":"5","key":"10.1016\/j.jgo.2023.101502_bb0100","doi-asserted-by":"crossref","first-page":"643","DOI":"10.14336\/AD.2017.0503","article-title":"Skin cancer epidemics in the elderly as an emerging issue in geriatric oncology","volume":"8","author":"Garcovich","year":"2017","journal-title":"Aging Dis."},{"issue":"5","key":"10.1016\/j.jgo.2023.101502_bb0105","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jaad.2021.04.047","article-title":"JAAD game changers\u2217: comorbidity scores associated with limited life expectancy in the very elderly with nonmelanoma skin cancer","volume":"85","author":"Lake","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.jgo.2023.101502_bb0110","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ejso.2020.10.037","article-title":"Outcomes of older adults aged 90 and over with cutaneous malignancies after electrochemotherapy with bleomycin: a matched cohort analysis from the InspECT registry","volume":"47","author":"Sersa","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.jgo.2023.101502_bb0115","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/annonc\/mdr587","article-title":"Screening older cancer patients: first evaluation of the G-8 geriatric screening tool","volume":"23","author":"Bellera","year":"2012","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.jgo.2023.101502_bb0120","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/annonc\/mdu210","article-title":"Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations","volume":"26","author":"Decoster","year":"2015","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.jgo.2023.101502_bb0125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.suronc.2009.11.008","article-title":"Assessment and treatment of elderly patients with cancer","volume":"19","author":"Balducci","year":"2010","journal-title":"Surg. Oncol."},{"issue":"9148","key":"10.1016\/j.jgo.2023.101502_bb0130","first-page":"205","article-title":"A brief clinical instrument to classify frailty in elderly people","volume":"353","author":"Rockwood","year":"1999","journal-title":"Lancet (British edition)"},{"issue":"5","key":"10.1016\/j.jgo.2023.101502_bb0135","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/jdv.12114","article-title":"Reconstruction of nasal defects with forehead flaps in patients older than 75 years of age","volume":"28","author":"Kendler","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.jgo.2023.101502_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-016-0329-8","article-title":"Frailty and post-operative outcomes in older surgical patients: a systematic review","volume":"16","author":"Lin","year":"2016","journal-title":"BMC Geriatr."},{"issue":"3","key":"10.1016\/j.jgo.2023.101502_bb0145","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.suronc.2009.11.011","article-title":"Age-related physiologic changes and perioperative management of elderly patients","volume":"19","author":"Colloca","year":"2010","journal-title":"Surg. Oncol."},{"issue":"2","key":"10.1016\/j.jgo.2023.101502_bb0150","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jaad.2019.09.009","article-title":"Nonmelanoma skin cancers are more likely to be untreated in elderly patients","volume":"82","author":"Basu","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.jgo.2023.101502_bb0155","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/DSS.0000000000002028","article-title":"Assessment of functionality in elderly patients when determining appropriate treatment for nonmelanoma skin cancers","volume":"46","author":"Renzi","year":"2020","journal-title":"Dermatol. Surg."},{"issue":"6","key":"10.1016\/j.jgo.2023.101502_bb0160","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jaad.2017.12.048","article-title":"Comorbidity scores associated with limited life expectancy in the very elderly with nonmelanoma skin cancer","volume":"78","author":"Rogers","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.jgo.2023.101502_bb0165","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cger.2013.01.011","article-title":"Common skin cancers in older adults: approach to diagnosis and management","volume":"29","author":"Council ML","year":"2013","journal-title":"Clin. Geriatr. Med."},{"issue":"4","key":"10.1016\/j.jgo.2023.101502_bb0170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijwd.2019.05.005","article-title":"Management of keratinocyte carcinoma - special considerations in the elderly","volume":"5","author":"Bailey","year":"2019","journal-title":"Int. J. Womens Dermatol."},{"issue":"5 Pt 1","key":"10.1016\/j.jgo.2023.101502_bb0175","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0190-9622(86)70251-X","article-title":"Cryosurgery of basal cell carcinoma","volume":"15","author":"Torre","year":"1986","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.jgo.2023.101502_bb0180","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0190-9622(94)70261-6","article-title":"Cryosurgery updated","volume":"31","author":"Kuflik","year":"1994","journal-title":"J. Am. Acad. Dermatol."},{"issue":"15","key":"10.1016\/j.jgo.2023.101502_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153720","article-title":"Advances in management and therapeutics of cutaneous basal cell carcinoma","volume":"14","author":"Chen","year":"2022","journal-title":"Cancers (Basel)."},{"issue":"22","key":"10.1016\/j.jgo.2023.101502_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25225398","article-title":"Photodynamic therapy for basal cell carcinoma: the clinical context for future research priorities","volume":"25","author":"Collier","year":"2020","journal-title":"Molecules."},{"issue":"5","key":"10.1016\/j.jgo.2023.101502_bb0195","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jaad.2019.10.079","article-title":"Photodynamic therapy for cutaneous squamous cell carcinoma in situ: impact of anatomic location, tumor diameter, and incubation time on effectiveness","volume":"82","author":"Kibbi","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.jgo.2023.101502_bb0200","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/bjd.14080","article-title":"No age-related decline in efficacy of photodynamic therapy for treatment of basal cell carcinoma","volume":"173","author":"Collier","year":"2015","journal-title":"Br. J. Dermatol."},{"issue":"8","key":"10.1016\/j.jgo.2023.101502_bb0205","first-page":"8523","article-title":"Efficacy analysis of the aminolevulinic acid photodynamic therapy combined with recombinant human interferon alpha-2b ointment in the treatment of precancerous skin lesions and superficial basal cell carcinoma in elderly patients","volume":"11","author":"Zhang","year":"2018"},{"issue":"3","key":"10.1016\/j.jgo.2023.101502_bb0210","first-page":"484","article-title":"Comparing topical treatments for Basal cell carcinoma","volume":"138","author":"Shaw","year":"2018"},{"issue":"1","key":"10.1016\/j.jgo.2023.101502_bb0215","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1470-2045(13)70530-8","article-title":"Surgery versus Imiquimod for nodular superficial basal cell carcinoma (SINS) study group. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial","volume":"15","author":"Bath-Hextall","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jgo.2023.101502_bb0220","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.addr.2019.11.002","article-title":"Topical treatments for skin cancer","volume":"153","author":"Cullen","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.jgo.2023.101502_bb0225","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/ijd.13597","article-title":"Cutaneous surgery under local anesthesia in very elderly patients 90 years of age and older is as safe as in elderly patients ranging in age from 75 to 80 years old","volume":"56","author":"Imamura","year":"2017","journal-title":"Int. J. Dermatol."},{"issue":"6","key":"10.1016\/j.jgo.2023.101502_bb0230","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bjps.2005.02.010","article-title":"Do basal cell carcinomas recur after complete conventional surgical excision?","volume":"58","author":"Griffiths","year":"2005","journal-title":"Br. J. Plast. Surg."},{"issue":"3","key":"10.1016\/j.jgo.2023.101502_bb0235","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jaad.2005.03.038","article-title":"Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas","volume":"53","author":"Kimyai-Asadi","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"issue":"11","key":"10.1016\/j.jgo.2023.101502_bb0240","article-title":"Mohs micrographic surgery versus standard excision for basal cell carcinoma in the head and neck: systematic review and meta-analysis Cureus","volume":"13","author":"Alsaif","year":"2021"},{"issue":"11","key":"10.1016\/j.jgo.2023.101502_bb0245","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.clon.2019.08.009","article-title":"Current concepts in the surgical management of non-melanoma skin cancers","volume":"31","author":"Kosutic","year":"2019","journal-title":"Clin. Oncol."},{"issue":"2","key":"10.1016\/j.jgo.2023.101502_bb0250","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/archderm.142.2.187","article-title":"Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face","volume":"142","author":"Essers","year":"2006","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jgo.2023.101502_bb0255","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/DSS.0000000000001973","article-title":"Mohs surgery in patients aged 75 years and older: patient-reported functional status and postoperative problems","volume":"46","author":"Sutton","year":"2020","journal-title":"Dermatol. Surg."},{"issue":"1","key":"10.1016\/j.jgo.2023.101502_bb0260","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.PRS.0000067479.77859.31","article-title":"Excision margins for nonmelanotic skin cancer","volume":"112","author":"Thomas","year":"2003","journal-title":"Plast. Reconstr. Surg."},{"issue":"6","key":"10.1016\/j.jgo.2023.101502_bb0265","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0190-9622(92)70144-5","article-title":"Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection","volume":"26","author":"Rowe","year":"1992","journal-title":"J. Am. Acad. Dermatol."},{"issue":"12","key":"10.1016\/j.jgo.2023.101502_bb0270","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.5858\/2005-129-1536-FSOSS","article-title":"Frozen section of skin specimens","volume":"129","author":"Smith-Zagone","year":"2005","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.jgo.2023.101502_bb0275","series-title":"Mohs micrographic surgery for cutaneous squamous cell carcinoma","first-page":"233","author":"Motley","year":"2019"},{"issue":"1","key":"10.1016\/j.jgo.2023.101502_bb0280","first-page":"263","article-title":"FRAIL scale as a predictor of complications and mortality in older patients undergoing reconstructive surgery for non-melanoma skin cancer","volume":"17","author":"Valdatta","year":"2019","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.jgo.2023.101502_bb0285","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaad.2021.05.041","article-title":"Predictors of surgical treatment burden, outcomes, and overall survival in older adults with basal cell carcinoma: results from the prospective, multicenter BATOA cohort","volume":"86","author":"van Winden","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.jgo.2023.101502_bb0290","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1440-1673.2008.01956.x","article-title":"The important role of radiotherapy in patients with non-melanoma skin cancer and other cutaneous entities","volume":"52","author":"Veness","year":"2008","journal-title":"J. Med. Imag. Radiat. Oncol."},{"key":"10.1016\/j.jgo.2023.101502_bb0295","doi-asserted-by":"crossref","first-page":"913269","DOI":"10.3389\/fmed.2022.913269","article-title":"The state of the art of radiotherapy for non-melanoma skin cancer: a review of the literature","volume":"9","author":"Benkhaled","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"issue":"5 Suppl","key":"10.1016\/j.jgo.2023.101502_bb0300","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.jaad.2005.12.035","article-title":"Chemoradiation using low-dose cisplatin and 5-fluorouracil in locally advanced squamous cell carcinoma of the skin: a report of two cases","volume":"55","author":"Fujisawa","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.jgo.2023.101502_bb0305","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/1754-9485.12718","article-title":"Efficacy of hypofractionated radiotherapy in patients with non-melanoma skin cancer: results of a systematic review","volume":"62","author":"Gunaratne","year":"2018","journal-title":"J. Med. Imag. Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.jgo.2023.101502_bb0310","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2018.01.013","article-title":"GEC-ESTRO ACROP recommendations in skin brachytherapy","volume":"126","author":"Guinot","year":"2018","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.jgo.2023.101502_bb0315","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jgo.2018.09.009","article-title":"The role of personalized interventional radiotherapy (brachytherapy) in the management of older patients with non-melanoma skin cancer","volume":"10","author":"Lancellotta","year":"2019","journal-title":"J. Geriatr. Oncol."},{"key":"10.1016\/j.jgo.2023.101502_bb0320","doi-asserted-by":"crossref","first-page":"2178469","DOI":"10.1155\/2018\/2178469","article-title":"Age is not a limiting factor in interventional radiotherapy (brachytherapy) for patients with localized Cancer","volume":"2018","author":"Lancellotta","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"10.1016\/j.jgo.2023.101502_bb0325","doi-asserted-by":"crossref","first-page":"165","DOI":"10.21037\/apm.2016.11.10","article-title":"Palliative radiotherapy for skin malignancies","volume":"6","author":"Vuong","year":"2017","journal-title":"Ann. Palliat. Med."},{"issue":"4","key":"10.1016\/j.jgo.2023.101502_bb0330","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.21873\/invivo.12501","article-title":"Palliative radiotherapy for cutaneous squamous cell carcinoma of the head-and-neck region","volume":"35","author":"Staackmann","year":"2021","journal-title":"In Vivo"},{"issue":"11","key":"10.1016\/j.jgo.2023.101502_bb0335","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.clon.2019.08.004","article-title":"Current role of radiotherapy in non-melanoma skin Cancer","volume":"31","author":"Veness","year":"2019","journal-title":"Clin. Oncol. (R Coll. Radiol.)"},{"issue":"4","key":"10.1016\/j.jgo.2023.101502_bb0340","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1805131","article-title":"PD-1 blockade with Cemiplimab in advanced cutaneous squamous-cell carcinoma","volume":"379","author":"Migden","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.jgo.2023.101502_bb0345","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJMoa0905360","article-title":"Inhibition of the hedgehog pathway in advanced basal-cell carcinoma","volume":"361","author":"Von Hoff","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jgo.2023.101502_bb0350","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/bjd.18552","article-title":"Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study","volume":"182","author":"Dummer","year":"2020","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.jgo.2023.101502_bb0355","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S1470-2045(21)00126-1","article-title":"Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-Centre, single-arm, phase 2 trial","volume":"22","author":"Stratigos","year":"2021","journal-title":"Lancet Oncol."},{"issue":"46","key":"10.1016\/j.jgo.2023.101502_bb0360","doi-asserted-by":"crossref","first-page":"76118","DOI":"10.18632\/oncotarget.12660","article-title":"Safety and efficacy of vismodegib in patients aged \u226565 years with advanced basal cell carcinoma","volume":"7","author":"Chang","year":"2016","journal-title":"Oncotarget."},{"issue":"14","key":"10.1016\/j.jgo.2023.101502_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143547","article-title":"Cemiplimab for locally advanced and metastatic cutaneous squamous-cell carcinomas: real-life experience from the French CAREPI study group","volume":"13","author":"Hober","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jgo.2023.101502_bb0370","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejca.2021.08.018","article-title":"Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma","volume":"157","author":"Baggi","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.jgo.2023.101502_bb0375","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000871","article-title":"Impact of age on the toxicity of immune checkpoint inhibition","volume":"8","author":"Samani","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jgo.2023.101502_bb0380","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejca.2020.07.023","article-title":"Safety and efficacy of atezolizumab in patients with autoimmune disease: subgroup analysis of the SAUL study in locally advanced\/metastatic urinary tract carcinoma","volume":"138","author":"Loriot","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jgo.2023.101502_bb0385","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejca.2017.12.008","article-title":"Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease","volume":"91","author":"Danlos","year":"2018","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.jgo.2023.101502_bb0390","first-page":"2100","article-title":"Safety and efficacy of immune checkpoint inhibitors in patients with cancer and preexisting autoimmune disease: a Nationwide, multicenter Cohort Study Arthritis Rheumatol","volume":"71","author":"Tison","year":"2019"},{"issue":"1","key":"10.1016\/j.jgo.2023.101502_bb0395","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/NCC.0000000000000843","article-title":"The symptom experience and self-management strategies of women undergoing cervical cancer treatment: a qualitative study","volume":"45","author":"Christiansen","year":"2022","journal-title":"Cancer Nurs."},{"issue":"2","key":"10.1016\/j.jgo.2023.101502_bb0400","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/hex.12640","article-title":"How to practice person-centred care: a conceptual framework","volume":"21","author":"Santana","year":"2018","journal-title":"Health Expect."},{"key":"10.1016\/j.jgo.2023.101502_bb0405","series-title":"A syllabus for the education and training of radiation oncology nurses","year":"2008"},{"key":"10.1016\/j.jgo.2023.101502_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2022.102203","article-title":"Experiences and perspectives of patients and clinicians in nurse-led clinics in an oncological setting: a sequential multi-methods study","volume":"61","author":"Gyldenvang","year":"2022","journal-title":"Eur. J. Oncol. Nurs."},{"issue":"11","key":"10.1016\/j.jgo.2023.101502_bb0415","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jamainternmed.2013.639","article-title":"Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer","volume":"173","author":"Linos","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jgo.2023.101502_bb0420","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamasurg.2017.5073","article-title":"Age at diagnosis as a relative contraindication for intervention in facial Nonmelanoma Skin Cancer","volume":"153","author":"Chauhan","year":"2018","journal-title":"JAMA Surg."},{"issue":"1","key":"10.1016\/j.jgo.2023.101502_bb0425","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/14737140.2023.2161517","article-title":"The current clinical approach to difficult-to-treat basal cell carcinomas","volume":"23","author":"Di Brizzi","year":"2023","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.jgo.2023.101502_bb0430","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejca.2019.06.003","volume":"118","author":"Peris","year":"2019","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.jgo.2023.101502_bb0435","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/jdv.17466","article-title":"Position statement on classification of basal cell carcinomas. Part 1: unsupervised clustering of experts as a way to build an operational classification of advanced basal cell carcinoma based on pattern recognition","volume":"35","author":"Grob","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406823000991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406823000991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:56:36Z","timestamp":1761818196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406823000991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1879406823000991"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2023.101502","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations of the International Society of Geriatric Oncology on skin cancer management in older patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2023.101502","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101502"}}